Results 191 to 200 of about 8,707,554 (306)

Histological Analysis of Cryopreserved Venous Allografts Used for Liver Transplantation and Hepato‐Biliary‐Pancreatic Surgery

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Background Cryopreserved venous allografts, which we pioneered in 1999 for use in living donor liver transplantation and hepato‐biliary‐pancreatic surgery, are widely used and are believed to preserve vascular architecture with minimal anticoagulation or immunosuppression requirements and patency comparable to autologous grafts.
Yusuke Seki, Akihiko Ichida, Sumihito Tamura, Mariko Tanaka, Yoshinori Inagaki, Kyoji Ito, Rihito Nagata, Takuya Hashimoto, Nobuhisa Akamatsu, Tetsuo Ushiku, Kiyoshi Hasegawa   +10 more
wiley   +1 more source

Portal Vein Thrombosis Risk in Cirrhotic Patients With Portal Hypertension on Beta-Blockers: A Multi-Institutional Cohort Study. [PDF]

Liver Int
Abosheaishaa H, Elfert K, Abusuliman M, Ismail A, Olimy A, Alzamzamy AE, Omran A, Rizzo V, Nassar M, El-Kassas M.   +9 more
europepmc   +1 more source

Acute massive gastric dilatation with necrosis and portal vein gas accumulation-a case report. [PDF]

Front Med (Lausanne)
He X, Wang J, Zhao Y, Ma S, Wang Z, Chen B, Yao Y.   +6 more
europepmc   +1 more source

Interleukin‐37 Enhances Liver NK Cell Cytotoxicity and Improves Recurrence‐Free Survival in Hepatocellular Carcinoma Patients

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Introduction Hepatocellular carcinoma (HCC) remains a major cause of cancer‐related mortality worldwide, and postoperative recurrence continues to limit long‐term survival. Liver‐resident natural killer (NK) cells are key effectors of antitumor immunity in the hepatic microenvironment. Interleukin‐37 (IL‐37), an anti‐inflammatory cytokine, has
Yuki Imaoka, Masahiro Ohira, Yuka Tanaka, Toshihiro Nakayama, Miho Akabane, Shinichiro Yokota, Sheri M. Krams, Olivia M. Martinez, Carlos O. Esquivel, Kazunari Sasaki, Hideki Ohdan   +10 more
wiley   +1 more source

Robotic-assisted pancreaticoduodenectomy: Portal vein-first vs artery-first approach. [PDF]

J Chin Med Assoc
Chen YS, Chen YJ, Chou CM, Chou CM.
europepmc   +1 more source

Portal Vein [PDF]

, 2020
openaire   +1 more source

The Hidden Architecture of Pancreatic Ducts: 3D Anatomical Reconstruction and Its Implication on Pancreatic Resection

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Background/Purpose Postoperative pancreatic fistula (POPF) is a common complication after pancreatic surgery and its mechanisms remain incompletely understood. While the diameter of the main pancreatic duct is well‐known to be a risk factor of POPF, the impact of branch duct's (BD) anatomy is not known.
Sébastien Frey, Luisa Nogueira, Sébastien Gaujoux, Karim Manai, Lilian Pimont, Karl Baqué, Michel Rayar, Nicolas Bronsard, Alain Sauvanet, Patrick Baqué   +9 more
wiley   +1 more source

Protocol for ultrasound-guided injection into the murine portal vein to initiate liver metastasis. [PDF]

STAR Protoc
Henning N, Roberts F, Spanoudaki V.
europepmc   +1 more source

Notation System for Liver Transplant Recipients: Key Information in Transplant Procedure

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Liver transplantation (LT) is a standard therapy for patients with end‐stage liver disease and certain hepatic malignancies. The LT procedure has diversified due to donor shortages and advances in immunosuppressive treatments and surgical techniques.
Hidenobu Kojima, Takashi Ito, Kei Yamane, Tomoaki Yoh, Shinya Okumura, Katsunori Sakamoto, Shoichi Kageyama, Satoshi Ogiso, Takayuki Anazawa, Yoichiro Uchida, Kazuyuki Nagai, Takamichi Ishii, Etsuro Hatano   +12 more
wiley   +1 more source

Portal Vein Tumor Thrombus in Hepatocellular Carcinoma: An Immune Sanctuary Driving Immune Exclusion and Therapeutic Resistance. [PDF]

Liver Cancer
Li X, Cheng Q, Zhu J, Yuan Z, Mu S, Zhou T, Gao J.   +6 more
europepmc   +1 more source